{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:49:52Z","timestamp":1764251392839},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":645,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1038\/mto.2015.8","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T13:50:49Z","timestamp":1432129849000},"page":"15008","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma"],"prefix":"10.1016","volume":"2","author":[{"given":"Ji Young","family":"Yoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Ge","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azeem","family":"Kaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quintin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavna","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Mazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros N","family":"Teknos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balveen","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew O","family":"Old","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mto.2015.8_bib1","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/cncr.20998","article-title":"Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years","volume":"103","author":"Shiboski","year":"2005","journal-title":"Cancer"},{"key":"10.1038\/mto.2015.8_bib2","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1200\/JCO.2006.07.1464","article-title":"Head and neck cancer: recent advances and new standards of care","volume":"24","author":"Forastiere","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1038\/mto.2015.8_bib3","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1158\/1078-0432.CCR-10-0196","article-title":"Phase I\/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III\/IV squamous cell cancer of the head and neck","volume":"16","author":"Harrington","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mto.2015.8_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2010.02.008","article-title":"United virus: the oncolytic tag-team against cancer!","volume":"21","author":"Le Boeuf","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1038\/mto.2015.8_bib5","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1158\/1078-0432.CCR-07-1639","article-title":"Nerve-sparing therapy with oncolytic herpes virus for cancers with neural invasion","volume":"13","author":"Gil","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mto.2015.8_bib6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/hed.20840","article-title":"Potential for efficacy of the oncolytic Herpes simplex virus 1716 in patients with oral squamous cell carcinoma","volume":"30","author":"Mace","year":"2008","journal-title":"Head Neck"},{"issue":"4 Pt 1","key":"10.1038\/mto.2015.8_bib7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00005537-200104000-00024","article-title":"The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma","volume":"111","author":"Cox","year":"2001","journal-title":"Laryngoscope"},{"issue":"4 Pt 1","key":"10.1038\/mto.2015.8_bib8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00005537-200104000-00024","article-title":"The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma","volume":"111","author":"Cox","year":"2001","journal-title":"Laryngoscope"},{"issue":"4A","key":"10.1038\/mto.2015.8_bib9","first-page":"1941","article-title":"Zinc concentrations in serum during head and neck cancer progression","volume":"27","author":"B\u00fcntzel","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1038\/mto.2015.8_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/mt.2011.187","article-title":"Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma","volume":"20","author":"Zhang","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mto.2015.8_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/07357907.2012.654870","article-title":"Angiogenesis inhibition using an oncolytic herpes simplex virus expressing endostatin in a murine lung cancer model","volume":"30","author":"Goodwin","year":"2012","journal-title":"Cancer Invest"},{"key":"10.1038\/mto.2015.8_bib12","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1158\/1078-0432.CCR-12-0697","article-title":"Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV","volume":"18","author":"Yoo","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mto.2015.8_bib13","first-page":"209","article-title":"Efficacy and tolerability assessment of a topical formulation containing copper sulfate and hypericum perforatum on patients with herpes skin lesions: a comparative, randomized controlled trial","volume":"11","author":"Clewell","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1038\/mto.2015.8_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1155\/MBD.1997.35","article-title":"Effect of complexes of zinc, cobalt and copper with D-aminosugars on the replication of herpes simplex virus type 1 (HSV-1)","volume":"4","author":"Shishkov","year":"1997","journal-title":"Met Based Drugs"},{"key":"10.1038\/mto.2015.8_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1155\/MBD.1998.19","article-title":"Effect of copper acyclovir complexes on herpes simplex virus type 1 and type 2 (HSV-1, HSV-2) infection in cultured cells","volume":"5","author":"Panteva","year":"1998","journal-title":"Met Based Drugs"},{"key":"10.1038\/mto.2015.8_bib16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.bjc.6604226","article-title":"Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)","volume":"98","author":"Do\u00f1ate","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1038\/mto.2015.8_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12011-013-9682-z","article-title":"Zinc and copper levels in bladder cancer: a systematic review and meta-analysis","volume":"153","author":"Mao","year":"2013","journal-title":"Biol Trace Elem Res"},{"key":"10.1038\/mto.2015.8_bib18","doi-asserted-by":"crossref","first-page":"e73684","DOI":"10.1371\/journal.pone.0073684","article-title":"Rapid copper acquisition by developing murine mesothelioma: decreasing bioavailable copper slows tumor growth, normalizes vessels and promotes T cell infiltration","volume":"8","author":"Crowe","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1038\/mto.2015.8_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fonc.2013.00028","article-title":"Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy","volume":"3","author":"Friedman","year":"2013","journal-title":"Front Oncol"},{"key":"10.1038\/mto.2015.8_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/jnci\/djj003","article-title":"Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication","volume":"98","author":"Aghi","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/mto.2015.8_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/gt.2012.31","article-title":"Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses","volume":"20","author":"Peng","year":"2013","journal-title":"Gene Ther"},{"key":"10.1038\/mto.2015.8_bib22","first-page":"1508","article-title":"Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma","volume":"63","author":"Cinatl","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/mto.2015.8_bib23","first-page":"7497","article-title":"Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer","volume":"63","author":"Freytag","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/mto.2015.8_bib24","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/oxfordjournals.aje.a010168","article-title":"Serum copper concentration and coronary heart disease among US adults","volume":"151","author":"Ford","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1038\/mto.2015.8_bib25","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1158\/1078-0432.CCR-08-0315","article-title":"Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumors","volume":"14","author":"Lowndes","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mto.2015.8_bib26","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1158\/1078-0432.CCR-06-0171","article-title":"Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1","volume":"12","author":"Juarez","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mto.2015.8_bib27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/1476-4598-9-206","article-title":"Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis","volume":"9","author":"Kumar","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1038\/mto.2015.8_bib28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.urolonc.2011.04.009","article-title":"A non-comparative randomized phase II study of 2 doses of ATN-224, a copper\/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-na\u00efve prostate cancer","volume":"31","author":"Lin","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1038\/mto.2015.8_bib29","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/AAC.41.4.812","article-title":"Mechanism of copper-mediated inactivation of herpes simplex virus","volume":"41","author":"Sagripanti","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1038\/mto.2015.8_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/mt.2009.232","article-title":"Enhanced antitumor efficacy of vasculostatin (Vstat120) expressing oncolytic HSV-1","volume":"18","author":"Hardcastle","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mto.2015.8_bib31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.gt.3302717","article-title":"Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models","volume":"13","author":"Terada","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/mto.2015.8_bib32","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1128\/JVI.74.8.3832-3841.2000","article-title":"Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice","volume":"74","author":"Sundaresan","year":"2000","journal-title":"J Virol"},{"key":"10.1038\/mto.2015.8_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0002-9440(10)63794-7","article-title":"Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression","volume":"162","author":"Kaur","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1038\/mto.2015.8_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/mthe.2002.0547","article-title":"The complement response against an oncolytic virus is species-specific in its activation pathways","volume":"5","author":"Wakimoto","year":"2002","journal-title":"Mol Ther"}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770516300109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770516300109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T05:56:34Z","timestamp":1566712594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770516300109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":34,"alternative-id":["S2372770516300109"],"URL":"https:\/\/doi.org\/10.1038\/mto.2015.8","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"article-number":"15008"}}